mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.06 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.06 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.07 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |